What Mobiquity Technologies Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Salkind Gene | Director | Sep 15 | Grant / award · A | +25,000 | $1.00 | +$25K | 8,668,695 |
| Salkind Gene | Director | Dec 30 | In/At-money Exercise · X | +420,000 | $0.50 | +$210K | 8,643,695 |
| Salkind Gene | Director | Aug 06 | Derivative Conversion · C | +7,675,160 | $0.20 | +$1.54M | 8,223,695 |
| Salkind Gene | Director | Oct 06 | Grant / award · A | +150,000 | $0.65 | +$97.5K | 448,535 |
| Salkind Gene | Director | Apr 12 | Grant / award · A | +1,385,663 | $0.17 | +$236K | 4,478,017 |
| Julia Dean | CEO | Apr 06 | Grant / award · A | +50,000 | $0.17 | +$8.35K | 54,884 |
| Provost Anne Schmidt | Director | Apr 06 | Grant / award · A | +50,000 | $0.17 | +$8.35K | 50,000 |
| Salkind Gene | Director | Apr 06 | Grant / award · A | +130,000 | $0.17 | +$21.7K | 3,092,354 |
| Salkind Gene | Director | Jun 30 | Derivative Conversion · C | +408,000 | $1.25 | +$510K | 2,992,354 |
| Salkind Gene | Director | Mar 30 | Derivative Conversion · C | +1,368,333 | $1.50 | +$2.05M | 2,484,354 |
| Barrett Don Walker Iii | Chief Oper. & Strategy Officer | Jan 03 | Grant / award · A | +25,000 | — | — | 25,000 |
| Salkind Gene | Director | Sep 30 | Exercise / conversion · M | +375,000 | — | — | 1,116,021 |
| Salkind Gene | Director | Sep 08 | Grant / award · A | +15,000,000 | $0.01 | +$150K | 296,318,355 |
| Salkind Gene | Director | Jul 21 | Grant / award · A | +15,000,000 | $0.01 | +$150K | 281,318,355 |
| Salkind Gene | Director | Sep 13 | Open-market buy · P | +12,500,000 | $0.04 | +$500K | 266,318,355 |
| Salkind Gene | Director | Sep 13 | Open-market buy · P | +127,500,000 | $0.02 | +$2.36M | 253,818,355 |
| Salkind Gene | Director | Sep 13 | Open-market buy · P | +35,000,000 | $0.01 | +$336K | 126,318,355 |
| Salkind Gene | Director | Jul 19 | Grant / award · A | +3,125,000 | $0.08 | +$250K | 91,318,355 |
| Salkind Gene | Director | Jul 14 | Grant / award · A | +12,500,000 | $0.04 | +$500K | 88,193,355 |
| Salkind Gene | Director | Jun 18 | Grant / award · A | +3,125,000 | $0.08 | +$250K | 75,693,355 |
Loading...
